Ticker LaunchReverse merger · Completed · ADYX
Adynxx, Inc.
Reverse merger with Alliqua BioMedical, Inc. (ALQA)
Adynxx, Inc. merged into Alliqua BioMedical, Inc. (ALQA), a Nasdaq-listed hydrogel and wound care products company, in a reverse merger that takes the private company public. The deal was announced on Oct 12, 2018 and closed on May 3, 2019. The combined company trades as Adynxx, Inc. (ADYX) on Nasdaq.
Adynxx is a clinical-stage biopharmaceutical company developing transcription factor decoy technology and first-in-class therapeutics for pain and inflammatory diseases, led by brivoligide for postoperative pain.
- Status
- Completed
- Private company
- Adynxx, Inc.
- Public company
- Alliqua BioMedical, Inc. (ALQA)
- Public company business before
- Nasdaq-listed hydrogel and wound care products company
- Announced
- Oct 12, 2018
- Closed
- May 3, 2019
- Combined company
- Adynxx, Inc. (ADYX)
- Exchange
- Nasdaq
- Sector
- Biotech & pharma
More on this deal for subscribers
- Ownership split between private and public holders
- Reverse stock split
- Analyst notes from the filings
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
Other completed reverse mergers
- Red Cat Propware, Inc.into TimefireVR Inc. · May 15, 2019
- C3J Therapeutics, Inc.into AmpliPhi Biosciences Corporation · May 10, 2019
- China VTV Ltd. (Hong Kong target)into China VTV Limited · May 8, 2019
- Charlie's Chalk Dust, LLCinto True Drinks Holdings, Inc. · Apr 26, 2019
- Oncotelic, Inc.into Mateon Therapeutics, Inc. · Apr 22, 2019
- Immunic AG (German private company)into Vital Therapies, Inc. · Apr 12, 2019